Nexo Therapeutics is a small molecule oncology company dedicated to the discovery and development of new drugs for cancer patients who currently lack meaningful therapies. Nexo combines covalent ligand discovery and chemical biology with expertise in cancer biology and medicinal chemistry to target fundamental drivers of cancer by innovative approaches. With facilities in Golden, CO and Watertown, MA, Nexo is led by Founder and CEO, Andrew Phillips, PhD. For more information, please visit www.nexotx.com.
Company Details
- Employees
- 20
- Founded
- -
- Address
- 500 Forge Road,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.nexotx.com/
- HQ
- Watertown, MA
Nexo Therapeutics Questions
Nexo Therapeutics's website is https://www.nexotx.com/
Nexo Therapeutics's LinkedIn profile is https://www.linkedin.com/company/nexo-therapeutics
Nexo Therapeutics has
20 employees.
View email and phone details for 20
employees at Nexo Therapeutics.
Nexo Therapeutics's industry is
Biotechnology Research
Nexo Therapeutics's top competitors are
Primrose Bio,
Scorpion Therapeutics,
Somaí,
Aleksia Therapeutics,
Catalym Gmbh,
Micropep Technologies,
Surge Therapeutics,
Kriya Therapeutics, Inc.,
Tisento Therapeutics,
Cardurion Pharmaceuticals.
Nexo Therapeutics's categories are Biotechnology Research
Nexo Therapeutics's founding year is 2022
